Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.25
(-0.78%)
USD 0.25
(-0.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.08 Million USD | 45.36% |
| 2022 | 748.29 Thousand USD | -23.56% |
| 2021 | 978.87 Thousand USD | 19.99% |
| 2020 | 815.81 Thousand USD | 0.0% |
| 2018 | 400 Thousand USD | 27.24% |
| 2017 | 314.37 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.15 Million USD | -10.06% |
| 2024 Q1 | 1.28 Million USD | 18.1% |
| 2023 Q1 | 1.55 Million USD | 107.56% |
| 2023 Q3 | 966.66 Thousand USD | 23.69% |
| 2023 FY | 1.08 Million USD | 45.36% |
| 2023 Q4 | 1.08 Million USD | 12.52% |
| 2023 Q2 | 781.51 Thousand USD | -49.68% |
| 2022 Q4 | 748.29 Thousand USD | -2.29% |
| 2022 FY | 748.29 Thousand USD | -23.56% |
| 2022 Q2 | 1.35 Million USD | 10.82% |
| 2022 Q1 | 1.22 Million USD | 25.2% |
| 2022 Q3 | 765.85 Thousand USD | -43.61% |
| 2021 FY | 978.87 Thousand USD | 19.99% |
| 2021 Q4 | 978.87 Thousand USD | 0.0% |
| 2020 FY | 815.81 Thousand USD | 0.0% |
| 2018 FY | 400 Thousand USD | 27.24% |
| 2017 FY | 314.37 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 99.839% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | 58.915% |
| Embecta Corp. | 1.63 Billion USD | 99.934% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 99.814% |
| PainReform Ltd. | 86 Thousand USD | -1164.76% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -65.377% |
| SCYNEXIS, Inc. | 15.08 Million USD | 92.787% |
| Journey Medical Corporation | 17.73 Million USD | 93.865% |
| Safety Shot Inc | 1.54 Million USD | 29.78% |
| Alpha Teknova, Inc. | 30.45 Million USD | 96.429% |
| Bright Green Corporation | 1.85 Million USD | 41.262% |
| Procaps Group, S.A. | 285.93 Million USD | 99.62% |
| Alvotech | 1.07 Billion USD | 99.899% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 99.655% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 98.899% |
| Cosmos Health Inc. | 12.42 Million USD | 91.245% |
| Dynavax Technologies Corporation | 256.91 Million USD | 99.577% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 99.799% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 93.578% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -65.377% |
| Theratechnologies Inc. | 58.96 Million USD | 98.155% |
| Harrow Health, Inc. | 190.5 Million USD | 99.429% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -78.897% |
| Biofrontera Inc. | 5.39 Million USD | 79.854% |
| DURECT Corporation | 20.74 Million USD | 94.757% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 97.381% |
| Cronos Group Inc. | 2.53 Million USD | 57.176% |
| OptiNose, Inc. | 131.74 Million USD | 99.174% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 99.848% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 97.005% |
| RedHill Biopharma Ltd. | 1.17 Million USD | 7.273% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 99.089% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 94.098% |
| Radius Health, Inc. | 365.31 Million USD | 99.702% |
| Universe Pharmaceuticals INC | 5.48 Million USD | 80.16% |
| ProPhase Labs, Inc. | 21.38 Million USD | 94.913% |
| Phibro Animal Health Corporation | 525.45 Million USD | 99.793% |
| Procaps Group S.A. | 285.93 Million USD | 99.62% |
| TherapeuticsMD, Inc. | 8 Million USD | 86.412% |
| Viatris Inc. | 18.12 Billion USD | 99.994% |
| Rockwell Medical, Inc. | 13.43 Million USD | 91.906% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 92.811% |
| SIGA Technologies, Inc. | 1.46 Million USD | 25.704% |
| Tilray Brands, Inc. | 387.31 Million USD | 99.719% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 99.166% |
| Shineco, Inc. | 29.65 Million USD | 96.332% |
| PetIQ, Inc. | 468.3 Million USD | 99.768% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -1718.673% |
| Incannex Healthcare Limited | 373 Thousand USD | -191.607% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 99.746% |
| Alimera Sciences, Inc. | 67.39 Million USD | 98.386% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 40.91 Million USD | 97.341% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | 86.858% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | 47.882% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -5.283% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 96.926% |
| Hempacco Co., Inc. | 13.72 Million USD | 92.075% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.07 Billion USD | 99.899% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 98.259% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 99.824% |
| Currenc Group, Inc. | 31.94 Million USD | 96.595% |
| Kamada Ltd. | 8.74 Million USD | 87.568% |
| Indivior PLC | 281.6 Million USD | 99.614% |
| Evoke Pharma, Inc. | 5 Million USD | 78.246% |
| Flora Growth Corp. | 3.67 Million USD | 70.379% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -5.283% |
| Evolus, Inc. | 126.54 Million USD | 99.14% |
| HUTCHMED (China) Limited | 86.13 Million USD | 98.737% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 99.826% |
| Akanda Corp. | 3.99 Million USD | 72.799% |